Skip to content
Home/Companies/Biotech/Vivoryon
Vivoryon

Vivoryon

Biotech·France·Exited 2014·Held 5yr
Entry
2009
Hold
5yr
Exit
2014

Who owns Vivoryon?

Vivoryon is a French Biotech company, formerly owned by Andera Partners, exited in 2014 (exit via IPO). No current private equity owner is on file.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Andera Partners
Investor
Andera Partners
BioDiscovery 3 · 2009 · VC

Key facts

HQFrance
SectorBiotech
Websitewww.vivoryon.com
Exit Type
IPO
Exit Year
2014

More from BioDiscovery 3

Other portfolio companies in the same fund.

Cellnovo
Exited 2015
MedTechFrance· 2011
GenKyoTex
Exited 2014
BiotechFrance· 2011
Sapiens
Sapiens
Exited 2013
SaaSFrance· 2011
to Medtronic
Covagen
Exited 2014
BiotechFrance· 2010
to Johnson & Johnson
Parvulus Medical
Exited
MedTechFrance· 2010
Poxel
Poxel
Active
BiotechFrance· 2010

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Vivoryon?

Vivoryon was formerly owned by Andera Partners, exited in 2014. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue